David Anderson, Chief Scientific Officer, VBI Vaccines
James Appleman, Senior Vice President Research and Development, Cso, Co-Founder And Director, Primmune Therapeutics, Inc.
Kimberly Armstrong, Chief of the Therapeutics Branch in the Influenza and Emerging Infectious Diseases Division, BARDA
Kabeer Aziz, Co-Founder & Principal, Adjuvant Capital
Jared Baeten, Vice President, HIV Clinical Development, Gilead Sciences
Carlos Bais, Senior Director, Oncology Biomarker Development, Genenetch Inc
Dr Jessica Baker Flechtner, Chief Scientific Officer, Genocea Biosciences
Lance Baldo, Chief Medical Officer, Adaptive Biotechnologies
Dr Carl Barrett, Vice President Of Translational Sciences, AstraZeneca
John Beigel, Associate Director, Clinical Research, National Institute of Health - NIAID
Sharon Benzeno, Chief Business Development Officer, Adaptive Biotechnologies
Dr. David Berd, Chief Medical Officer, BioVaxys Technology Corp.
Prof. Pamela Bjorkman, David Baltimore Professor of Biology and Biological Engineering, California Institute of Technology
Mohan Bolisetty, Associate Director, Bristol-Myers Squibb
Dr Matthew Bosse, VP and Global Medical Lead, ViiV Healthcare
Maria Elena Bottazzi, Co-Director, Texas Children’s Hospital Center for Vaccine Development, Baylor College of Medicine
Abby Bownas, Principal, AVAC
Dr Sarah Browne, Senior Director, Clinical Development, Altimmune
Rob Burgess, Chief Business Officer, Sino Biological Inc
Dr Dennis Burton, Co-chair Department of Immunology and Microbiology, The Scripps Research Institute
David Canton, Senior Director, R&D And Clinical Science, OncoSec Medical
Tony Chen, President And Chief Executive Officer, PrimeVax Immuno Oncology Inc
Dr Tomas Cihlar, Vice President, Virology, Gilead Sciences, Inc.
Dr Ezra Cohen, Associate Director Of Moores Cancer Center, U.C. San Diego Moores Cancer Center
Dr Lynn Connolly, CMO, Adagio Therapeutics
Dr James Crowe, Director, Vanderbilt Vaccine Center
James Crowe, Director, Vanderbilt Vaccine Center
Dr Diane Da Silva, Associate Director, Translational Medicine, Parker Institute for Cancer Immunotherapy
Jason Devoss, Director, Amgen
Manisha Diaz, BioPharma R&D Scientific Manager, Eurofins Viracor
David Dominguez, Research Associate, Takeda
Dr John Dye, Chief, Viral Immunology, Acting Deputy, Foundational Sciences, U.S. Army Medical Research Institute of Infectious Diseases
Denise Foster, COVID-19 Vaccine Clinical Director, Chief Nursing Officer, Medical Care Services, County of San Diego Health and Human Services
Dr Felix Frueh, CSO and Co-Founder, Selva Therapeutics, Inc.
Dr Hanspeter Gerber, CSO, 3T Biosciences
Jeffrey Glenn, Professor of Medicine and of Microbiology & Immunology, stanford university
John Gregg, CEO, BALINBAC THERAPEUTICS, INC.
Dr Guido Gualdoni, CEO, G.ST Antivirals
Dr Farshad Guirakhoo, CSO, Vaxxinity
Kathryn Hashey, US Vaccine Policy Lead, GSK
Mary Hauser, Senior Scientist, GeoVax, Inc.
Daniel Henderson, CEO, CSO, Verndari
Dr Karl Hostetler, Professor of Medicine, University of California San Diego
Michael Humbert, Co-Founder & CTO, NTx
Dr Laurent Humeau, Chief Scientific Officer, Evp Of Research, Engineering And Clinical Developments, Inovio Pharmaceuticals
Eric Ibsen, CEO & Co-Founder, Studylog
Dr Michael G Ison, Professor Of Medicine, Northwestern University
Dr Amy Jenkins, Program Manager, D.A.R.P.A.
Karin Jooss, CSO, Gritstone Oncology
Dr Adeela Kamal, Vice-President R&D, Therapeutics, Emergent BioSolutions
Maria Karasarides, Vice-President, Head Early Assets & Biomarkers, Bristol-Myers Squibb
Scott Kelly, CMO, CytoDyn, Inc.
Alexander Kort, SVP Corporate Development, Themis Bioscience
Tom Lake, SVP, Strategic Alliances & Commercialization, Vaxxas
Rekha Lakshmanan, Director, Advocacy And Policy, The Immunization Partnership
Brandon Lamarche, Principal Scientist, Head of xCELLigence Application Development, Agilent
Theresa Lavallee, VP Translational Medicine and Regulatory Affairs, Parker Institute for Cancer Immunotherapy
Sam Lee, President, Cocrystal Pharma, Inc.
Dr John Lewis, CEO, Aegis Life, Inc.
Rachel Liberatore, Director of Research & Development, Renbio
Dr Elke Lipka, Ph.D, MBA, CEO, TSRL, Inc
Dr Tyler Martin, Chairman, President & CEO, Adjuvance Technologies
Kevin Mccowen, Southwest Regional Manager, Wyatt Technology Corporation
Mark McDade, Managing Partner, Qiming Venture Partners
Dr James Merson, Global Therapeutic Area Head, Infectious Diseases, Janssen
Jacqueline Miller, Senior Vice President, Therapeutic Area Head, Infectious Disease, Moderna Therapeutics
Sandrine Miller Montgomery, President & CEO, Micronoma
Martin Moore, Chief Executive Officer, Meissa Vaccines, Inc
Vincent Munster, Chief of Virus Ecology Unit, NIAID, NIH
Mark Newman, CSO, GeoVax, Inc.
Dr Neal Padte, Chief Operating Officer & Chief Development Officer, Renbio
Dr Wendy Painter, Chief Medical Officer, Ridgeback Biotherapeutics
Dr George Painter, Professor of Pharmacology and Chemical Biology, Emory University
Joe Payne, Founder, President & Chief Executive Officer, Arcturus Therapeutics
Robert Popovian, Senior Health Policy Fellow, Progressive Policy Institute
Krishna Prasad, Founder, Citranvi Biosciences LLC
Kamal Puri, CSO, OncoResponse, Inc.
Dr Barbara Rath, Co-foudner & Chair, Vienna Vaccine Safety Initiative
Dr Douglas Richman, Director, Center for Aids Research, University of California San Diego
Paul Robbins, Vice President, Translational Oncology, Instil Bio
Bridget Sandusky, Technical Sales Specialist – West Coast, indevr
Stephen Schoenberger, Professor, La Jolla Institute for Allergy and Immunology
Robert Schooley, Distinguished Professor of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego
Alessandro Sette, Center Head, Division Head, And Professor,, La Jolla Institute for Allergy and Immunology
Dr Robert Shafer, Professor of Medicine-Infectious Diseases, Stanford University School of Medicine (USA)
Adam Simpson, Co-Founder And Chief Executive Officer, Icosavax, Inc.
William Smith, Chief Executive Officer, Alliance for Multispecialty Research LLC
Tim Soos, Director Immunology, Codiak Biosciences
Dr Erin Spiegel, VP Clinical & Regulatory Affairs, PharmaJet
Dr Eddie Sullivan, President, Chief Executive Officer And Co-Founder, Sab Biotherapeutics Inc
Dr Todd Suscovich, Chief Technical Officer, Seromyx
Dr Vu Truong, Chief Executive Officer And Chief Scientific Officer, Aridis Pharmaceuticals
Dr Heidi Trusheim, Head of Process Development, IDT Biologika
Dr Sean Tucker, Chief Scientific Officer And Vice President Research, Vaxart
Dr Andrew Vaillant, Chief Scientific Officer, Replicor Inc.
Prof. Wim Van Criekinge, Professor, myNEO NV
James Wassil, COO, Vaxcyte
Dr Ariel Weinberger, CEO, Autonomous
Dr Michael Wohlfeiler, Chief of Medicine, AIDS Healthcare Foundation
Dr Benjamin Young, Head Of Global Medical Directors, ViiV Healthcare